Abstract:Microsatellite instability (MSI) is an important genomic biomarker for cancer diagnosis and treatment, and sequencing-based approaches are often applied to identify MSI because of its fastness and efficiency. These approaches, however, may fail to identify MSI on one or more sub-clones for certain cancers with a high degree of heterogeneity, leading to erroneous diagnoses and unsuitable treatments. Besides, the computational cost of identifying sub-clonal MSI can be exponentially increased when multiple sub-clones with different length distributions share MSI status. Herein, this paper proposes "scMSI", an accurate and efficient estimation of sub-clonal MSI to identify the microsatellite status. scMSI is an integrative Bayesian method to deconvolute the mixed-length distribution of sub-clones by a novel alternating iterative optimization procedure based on a subtle generative model. During the process of deconvolution, the optimized division of each sub-clone is attained by a heuristic algorithm, aligning with clone proportions that adhere optimally to the sample's clonal structure. To evaluate the performance, 16 patients diagnosed with endometrial cancer, exhibiting positive responses to the treatment despite having negative MSI status based on sequencing-based approaches, were considered. Excitingly, scMSI reported MSI on sub-clones successfully, and the findings matched the conclusions on immunohistochemistry. In addition, testing results on a series of experiments with simulation datasets concerning a variety of impact factors demonstrated the effectiveness and superiority of scMSI in detecting MSI on sub-clones over existing approaches. scMSI provides a new way of detecting MSI for cancers with a high degree of heterogeneity. Microsatellites are short, repetitive sequences of DNA, and their instability (MSI) is an important marker for cancer diagnosis and treatment. However, tumors often consist of diverse groups of cells, or sub-clones, and existing sequencing methods often fail to detect MSI that occurs only in some sub-clones. This can lead to incorrect diagnoses and prevent patients from receiving the most effective therapies. To solve this problem, we developed a new computational method named as scMSI to accurately identify MSI of sub-clones within a tumor. scMSI utilizes advanced statistical techniques to deconvolute the complex mixture of genetic mutations. As a result, we can use scMSI to detect sub-clonal MSI that other methods might miss. In the testing, we examined scMSI on samples from 16 patients with endometrial cancer, who had been incorrectly labeled as MSI-negative by existing methods. Our method successfully identified MSI in sub-clones, showing that scMSI outperforms existing tools. Additionally, simulation experiments under various conditions further confirmed the effectiveness of scMSI in detecting sub-clonal MSI. By improving the detection of MSI in cancers with a high degree of heterogeneity, scMSI can enhance cancer diagnosis and treatments more effectively.

DeltaMSI: artificial intelligence-based modeling of microsatellite instability scoring on next-generation sequencing data

A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing.

Long deletion signatures in repetitive genomic regions track somatic evolution and enable sensitive detection of microsatellite instability

Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning

scMSI: Accurately inferring the sub-clonal Micro-Satellite status by an integrated deconvolution model on length spectrum

MSIsensor-ct: microsatellite instability detection using cfDNA sequencing data

Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study

A novel algorithm for the detection of microsatellite instability in endometrial cancer using next‐generation sequencing data

Abstract 7560: Microsatellite instability (MSI) detection using flow-based sequencing

One-instrument, objective microsatellite instability analysis using high-resolution melt

Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application

MSINGB: A Novel Computational Method Based on NGBoost for Identifying Microsatellite Instability Status from Tumor Mutation Annotation Data

Accurate Pan-Cancer Molecular Diagnosis of Microsatellite Instability by Single-Molecule Molecular Inversion Probe Capture and High-Throughput Sequencing

Evaluating the Microsatellite Instability of Colorectal Cancer Based on Multimodal Deep Learning Integrating Histopathological and Molecular Data

Artificial Intelligence Models for the Detection of Microsatellite Instability from Whole-Slide Imaging of Colorectal Cancer

Artificial Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer

Validation of MSIntuit as an AI-based pre-screening tool for MSI detection from colorectal cancer histology slides

Artificial Intelligence for Predicting Microsatellite Instability Based on Tumor Histomorphology: A Systematic Review

The ATOM-Seq sequence capture panel can accurately predict microsatellite instability status in formalin-fixed tumour samples, alongside routine gene mutation testing

A Method for Improving the Detection Accura-cy of MSIsensor Based on Downsampling

Evaluating multiple next-generation sequencing derived tumor features to accurately predict DNA mismatch repair status